Overview

The United States Eye Care Market was valued at USD 34.9 billion in 2025 and is projected to reach USD 64.2 billion by 2034, growing at a CAGR of 7.2% during the forecast period (2026–2034). The market is driven by rising vision disorders, an aging population, and increasing demand for advanced eye care solutions. The market is shifting from episodic vision correction toward recurring, technology-enabled disease management. Ocular health therapeutics for dry eye, retinal disease, and glaucoma are gaining share alongside traditional eyeglasses and contact lenses, while artificial intelligence-based retinal screening tools are expanding the diagnostic funnel by converting previously undiagnosed disease burden into active treatment demand. Government and regulatory activity continues to shape the market, with the FTC's update to the Eyeglass Rule improving prescription portability across fulfillment channels and reinforcing the shift toward omnichannel and online purchasing, while persistent Medicaid coverage gaps for routine adult eye exams and eyewear in non-expansion states continue to constrain utilization among lower-income and older adult populations despite rising clinical need. The South is the dominating region, reflecting the concentration of diabetes-linked diabetic retinopathy demand and an aging population across Texas, Florida, and the Southeast. The West is the fastest-growing region, supported by early, large-scale adoption of AI-assisted retinal screening within integrated health systems such as Sutter Health in California and continued Sun Belt population growth.

Market Size & Share

Market Dynamics

KEY MARKET TREND:

AI-Powered Retinal Screening Emerging as a Transformational Trend

• Autonomous AI-assisted retinal screening tools are being deployed directly within primary care practices, allowing diabetic eye exams to be completed during a routine visit rather than requiring a separate ophthalmology referral.
• Health systems adopting these tools are seeing measurable improvements in diabetic eye exam compliance, converting previously undetected disease burden into active referrals and treatment demand for downstream ophthalmology and optometry providers.
• Electronic health record integration is becoming a key differentiator for AI screening vendors, since embedding autonomous screening directly into existing clinical workflows removes a major adoption barrier for time-constrained primary care practices.
• Sutter Health's California-wide deployment of AI retinal cameras across 28 primary care practices improved diabetic eye exam compliance from 62% to 68%, illustrating the scale of impact autonomous screening can have when embedded directly into a large integrated health system's existing primary care network.

KEY MARKET DRIVER

Aging-Linked Ocular Disease Burden and Screen-Time-Driven Vision Correction Demand are the Key Drivers

• The aging US population continues to expand the base of patients requiring ongoing treatment for glaucoma, cataracts, diabetic retinopathy, and age-related macular degeneration, sustaining consistent utilization across both clinical and consumer channels.
• Rising screen time is expanding the addressable market for digital eye strain, dry-eye, and vision correction products, with full-time employees averaging roughly 97 hours of weekly screen time in 2025 and a majority reporting digital eye strain symptoms.
• Expanding managed vision care coverage is encouraging more routine exams, eyewear purchases, and replenishment cycles, with roughly half of US households covered by a managed vision care plan in 2025.
• More than 4.2 million US adults were affected by glaucoma, and the population aged 65 and older exceeds 54 million, underscoring the scale of the chronic ocular disease burden that continues to drive recurring demand for both clinical treatment and vision correction products.

KEY MARKET OPPORTUNITY

Premium Surgical and Implantable Product Innovation Creating Significant Market Opportunity

• Continued innovation in premium intraocular lens technology is creating opportunities for manufacturers to capture higher-value content per cataract procedure as patients increasingly opt for advanced, adjustable, or extended-depth-of-focus lens options over standard monofocal lenses.
• Growing clinical adoption of corneal cross-linking and other minimally invasive procedures for conditions such as keratoconus is expanding the addressable surgical market beyond traditional cataract and refractive procedures.
• Tele-optometry partnerships that pair national retail footprints with remote licensed optometrists are opening access to routine eye exams in rural and underserved markets that have historically lacked a local optometrist.
• VSP Vision's benefits network structure, which reaches roughly half of US households through managed vision care coverage, illustrates how embedding eye care access inside employer and insurance benefit design continues to drive recurring exam and eyewear replenishment demand independent of any single retail partnership.

United States Eye Care Market Size, 2025-2034 (USD Billion)

Segmentation Analysis

Analysis by Product Category

Vision correction products held the largest market share in 2025, supported by the widespread and recurring use of eyeglasses, contact lenses, and other refractive correction products among the large U.S. population experiencing vision impairment. Routine replacement cycles, increasing awareness of vision correction needs, broad access through clinical, optical retail, and online channels, and rising screen-related vision issues continue to strengthen demand, while regular prescription updates and product replacement further reinforce vision correction as the largest product category by revenue.

Ocular health products are projected to be the fastest-growing segment during the forecast period, driven by rising demand for dry-eye therapies, anti-VEGF retinal treatments, and premium ocular supplements. This growth reflects the market's broader shift from episodic vision correction toward recurring, technology-enabled disease management, supported by increasing prevalence of chronic eye conditions and greater demand for ongoing therapeutic care.

Product categories include

              ·           Vision Correction Products (Dominating Segment)

              ·           Ocular Health Products (Highest CAGR Segment)

              ·           Surgical & Implantable Products

              ·           Diagnostics & Monitoring Systems

              ·           Others

Analysis by Mode of Purchase

Prescribed products held the leading position in 2025, supported by the continued importance of licensed eye-care professionals in prescribing eyewear, specialty contact lenses, surgical implants, and retinal therapies. High-value clinical treatments remain closely linked to the Rx channel, while digital prescription tools are improving portability and expanding fulfillment options across online and omnichannel platforms. The growing prevalence of refractive errors, retinal disorders, and other chronic eye conditions further sustains demand for professionally prescribed products and recurring clinical care.

Over-the-counter products are projected to be the fastest-growing segment during the forecast period, supported by increasing consumer spending on dry-eye drops, ocular vitamins, and allergy-related eye-care products, along with aging demographics and the growing emphasis on preventive self-care. The FTC's update to the Eyeglass Rule, which improved prescription portability across fulfillment channels, is also reducing the distinction between prescribed and consumer-directed purchasing. Greater availability of OTC products through pharmacies, optical retailers, e-commerce platforms, and other consumer channels is further improving accessibility and encouraging self-directed eye-care management.

Mode of Purchase categories include

              ·           Prescribed Products (Dominating Segment)

              ·           Over-the-Counter Products (Highest CAGR Segment)

Analysis by Distribution Channel

Ophthalmology clinics and optometry stores held the leading position in 2025, supported by patients' continued reliance on in-person visits for eye examinations, contact lens fittings, prescription eyewear selection, and other high-value product decisions. More than 80% of prescription frame and ophthalmic lens transactions occurred in person as of 2026, underscoring the continued importance of physical clinics and optical stores despite expanding digital fulfillment options. The need for professional diagnosis, prescription verification, personalized fitting, and clinical consultation further strengthens the role of these physical channels across the eye care market.

The online channel is projected to be the fastest-growing distribution segment during the forecast period, driven by the convenience of digital ordering for contact lens replenishment and prescription eyewear purchases. Hybrid retail models that integrate physical stores with e-commerce, together with tele-optometry partnerships that extend digital prescription workflows into underserved markets, are accelerating online adoption relative to purely offline or purely digital approaches. Improved home-delivery services, broader digital payment options, and easier prescription management are further encouraging consumers to shift routine eye-care purchases toward online platforms.

Distribution Channel categories include

              ·           Ophthalmology Clinics & Optometry Stores (Dominating Segment)

              ·           Online Channel (Highest CAGR Segment)

              ·           Optical Retail Chains

              ·           Retail Pharmacies

              ·           Ambulatory Surgery Centers

              ·           Hospitals

Analysis by Demographic

Adults held the leading position in 2025, supported by workplace vision benefits, routine eyewear demand, and screen-induced eye strain, alongside managed vision care coverage reaching roughly half of U.S. households. The working-age population's combination of high labor-force participation, employer-sponsored benefits, and extensive screen exposure keeps it the largest demographic segment by revenue. Frequent prescription updates, contact lens use, and preventive eye examinations further contribute to sustained demand within this segment.

The geriatric segment is projected to be the fastest-growing demographic segment during the forecast period, driven by rising cataract procedure volumes, anti-VEGF therapy for retinal diseases, and ongoing glaucoma management as the U.S. population aged 65 and older continues to expand. Sustained treatment needs associated with chronic, age-related ocular conditions are expected to drive stronger growth than the broader market. Increasing demand for regular eye examinations, surgical interventions, and long-term disease monitoring further reinforces spending on eye care among older adults.

Demographic categories include

              ·           Adults (Dominating Segment)

              ·           Geriatric (Highest CAGR Segment)

              ·           Children & Adolescents

By Region

United States Eye Care Market Regional Analysis

United States Eye Care Market Share 2025, (CAGR)

North America

XX%

South America

XX%

Europe

XX%

Middle East Africa

XX%

Asia Pacific

XX%

Regional Analysis

The South held the leading position in 2025, supported by elevated diabetes rates and strong demand for diabetic retinopathy screening and treatment across Texas, Georgia, and the Carolinas, along with Florida's large aging population driving cataract surgery, anti-VEGF injections, and glaucoma management volumes. Value-driven retail optical chains also help convert unmet clinical needs into actual visits and purchases, particularly in areas where high disease prevalence is combined with uneven insurance coverage and affordability challenges across Medicaid non-expansion states. The region's large population base and substantial burden of chronic eye conditions further sustain demand for both routine and specialized eye-care services.

The West is projected to be the fastest-growing regional segment during the forecast period, driven by early, large-scale adoption of AI-assisted retinal screening within integrated health systems such as California's Sutter Health, alongside continued Sun Belt population growth across the broader region. The combination of technology-focused healthcare systems and an expanding population base is widening the diagnostic funnel and converting previously undetected eye disease into active treatment demand at an above-average pace compared with the more clinically mature Northeast market. Growing healthcare technology adoption, increasing access to specialized ophthalmic services, and rising awareness of preventive eye care are further strengthening regional demand.

Regions Covered

              ·           South

              ·           West

              ·           Northeast

              ·           Midwest 

Market Share

The US Eye Care Market is consolidated, with a small group of multinational players, including Alcon, Allergan Eye Care (a unit of AbbVie), Johnson & Johnson Vision Care, Bausch + Lomb, and EssilorLuxottica, dominating the premium product categories through extensive portfolios, strong clinician relationships, and large-scale manufacturing or retail platforms spanning surgical devices, ophthalmic pharmaceuticals, lenses, and optical retail. Outside these major multinationals, competition is more fragmented and diverse: Warby Parker competes on integrated physical stores, e-commerce, and insurance partnerships, National Vision Holdings competes on affordable pricing and managed-care alignment, and VSP Vision leverages its benefits network to drive recurring exam and eyewear demand. A distinct emerging competitive layer is forming around AI-driven diagnostic companies such as AEYE Health, which target early disease detection and remote screening access, particularly in primary care and underserved regions. Key success factors include regulatory approval capability for premium surgical and pharmaceutical products, integration with clinical workflows and electronic health record systems for diagnostic technologies, and the ability to serve both high-value clinical channels and value-oriented retail channels simultaneously.

Key Players

              ·           AbbVie Inc. (Allergan Eye Care) (US)

              ·           Alcon Inc. (Switzerland)

              ·           Bausch + Lomb Corporation (Canada)

              ·           Carl Zeiss Meditec AG (Germany)

              ·           CooperVision, Inc. (The Cooper Companies) (US)

              ·           EssilorLuxottica SA (France)

              ·           Glaukos Corporation (US)

              ·           Harrow, Inc. (US)

              ·           HOYA Corporation (Japan)

              ·           Johnson & Johnson Vision Care, Inc. (US)

              ·           National Vision Holdings, Inc. (US)

              ·           NIDEK Inc. (Japan)

              ·           Regeneron Pharmaceuticals, Inc. (US)

              ·           RxSight, Inc. (US)

              ·           Santen Pharmaceutical Co., Ltd. (Japan)

Recent Market Developments

• April 2026: Alcon introduced Clareon TruPlus, an advanced monofocal and toric intraocular lens that enhances its existing Clareon platform with improved depth-of-focus, expanding its presence in the premium intraocular lens market.
• April 2026: Johnson & Johnson announced an investment of more than $1 billion in Jacksonville, Florida, to expand U.S.-based manufacturing, packaging, and distribution capacity for ACUVUE contact lenses. The investment is expected to strengthen domestic supply, increase production capacity, and support growing demand in the U.S. eye-care and contact-lens market.
• July 2025: Alcon commercially launched TRYPTYR (acoltremon) in the U.S., adding a new prescription treatment for dry eye disease and expanding treatment options for the large U.S. dry-eye patient population. The launch strengthens Alcon’s position in the U.S. ocular-health market and expands its prescription dry-eye portfolio.
• February 2025: Alcon launched SYSTANE PRO Preservative-Free in the U.S., expanding its dry-eye treatment portfolio with a preservative-free lubricant eye drop. The launch strengthens Alcon’s position in the U.S. ocular-health market and provides an additional option for consumers seeking dry-eye relief.

Frequently Asked Questions

Key Questions Answered

Request a Sample

1

What products and services does the eye care market include?

2

What is the CAGR of the United States Eye Care Market?

3

Which product category leads the United States Eye Care Market?

4

Which distribution channel is growing fastest?

5

How is the aging population affecting eye care demand?

6

What role does AI play in eye disease screening?

7

Which region is growing fastest for eye care in the United States?

Why Choose IG Transformation

Speak to Analyst

Strong Industry Focus

Extensive Product Offerings

Customer Research Services

Robust Research Methodology

Comprehensive Reports

Latest Technological Developments

Value Chain Analysis

Potential Market Opportunities

Growth Dynamics

Quality Assurance

Post-sales Support

Regular Report Updates